BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• BioMidwest

  Retrofit draws on top female talent to transform lives

  Firms that receive venture capital funding in the U.S. tend to be founded and led by men, according to a Harvard University study.

  April 2, 2018

   · 

  1 min read
• Business

  Nationally Renowned Cardiologist, Kimberly Parks, MD, Establishes Groundbreaking Concierge Practice: Synergy Private Health

  Castle Connolly Private Health Partners, LLC, in collaboration with Newton-Wellesley Hospital, and renowned cardiologist, Dr. Kimberly Parks, is pleased to announce the formation of Synergy Private Health- a pioneering approach to primary and cardiac care.

  April 2, 2018

   · 

  5 min read
• Business

  BewellConnect Partners with Janz Corporation

  Visiomed Group announced the signing of a partnership agreement between American subsidiary BewellConnect® and Janz Corporation.

  April 2, 2018

   · 

  4 min read
• FDA

  Dr. Reddy’s Laboratories and its U.S. subsidiary Promius Pharma announce the filing of an NDA for its migraine candidate

  Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC, today announced the filing of New Drug Application (NDA) for its migraine candidate DFN-02 with the U.S. Food and Drug Administration (USFDA).

  April 2, 2018

   · 

  3 min read
• BioCapital

  InVitria Expands Portfolio of Animal-Free Cell Culture Tools with New Plant Hydrolysate-Free Chemically Defined VERO Media for Virus Production

  OptiVERO Outperforms Popular Serum-Free Media, Enables Commercial Development of Novel Viral Vaccines

  April 2, 2018

   · 

  2 min read
• Business

  Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products

  Compugen will receive $10 million upfront, and is eligible for milestone payments and royalties on any products developed under the license

  April 2, 2018

   · 

  5 min read
• Business

  BioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% Sequentially

  2018 Revenue Guidance Revised Upward

  April 2, 2018

   · 

  4 min read
• Business

  Bardy Diagnostics™ Names Ken Nelson Chief Commercial Officer

  He will serve on the company’s Executive Committee and be responsible for leading Bardy Diagnostics’ Global Sales, Marketing, Business Development, and Customer Experience functions.

  April 2, 2018

   · 

  4 min read
• FDA

  Cardiome Highlights Partner SteadyMed’s Progress Towards Trevyent NDA Resubmission

  Trevyent® is for the treatment of pulmonary arterial hypertension

  April 2, 2018

   · 

  6 min read
• Biotech Bay

  Intersect ENT Announces Launch of SINUVA™ Sinus Implant, a New In-Office Treatment Option for Recurrent Nasal Polyps

  New Treatment Is Clinically Proven to Reduce Polyps and Symptoms of Nasal Congestion

  April 2, 2018

   · 

  9 min read